{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-070970","form_type":"8-K","ticker":"PFSA","cik":"0001859807","company_name":"Profusa, Inc.","filed_at":"2026-06-23T17:00:24+00:00","discovered_at":"2026-06-23T17:01:00.558480+00:00","generated_at":"2026-06-23T17:01:13.841875+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Profusa shareholders approve reverse stock split, asset acquisition, and equity plan amendments","bullets":["Elected Lauren Chung as Class I director with 631,502 FOR votes.","Approved reverse stock split (1:5 to 1:200) at board's discretion through June 2028.","Approved issuance of convertible preferred stock and common shares to Bio Insights LLC for PanOmics Assay acquisition.","Approved potential >19.99% share issuance upon conversion of promissory note to NorthView Sponsor I LLC.","Approved increase in 2025 Equity and Incentive Plan shares from 100,386 to 795,930."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-070970","json":"https://secwatch.observer/filing/0001213900-26-070970.json","markdown":"https://secwatch.observer/filing/0001213900-26-070970.md","text":"https://secwatch.observer/filing/0001213900-26-070970.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026070970/0001213900-26-070970-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026070970/ea0295656-8k_profusa.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T17:01:13.841875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}